Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 02/12/2008 import_03975_de.jpg

    Cancer cells do not like rocket salad

    Isothiocyanates which are substances found in vegetables such as rocket kohlrabi or mustard promote good health. Dr. Evelyn Lamy and her team at the Freiburg University Hospital found out that isothiocyanates lead to considerably fewer DNA strand breaks.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cancer-cells-do-not-like-rocket-salad
  • Article - 29/11/2008 Small greenish worms

    The worm in humans

    Caenorhabditis elegans has a lifespan of 20 days. The worm is as small as a comma and consists of only 959 cells. Caenorhabditis elegans is very different from Homo sapiens who might at least in Germany live for as long as 79 years or more. Nevertheless the tiny worm is the most important model organism for researchers into ageing who use it to study the development of age-related diseases and the ageing process itself.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-worm-in-humans
  • Article - 29/11/2008

    Telomeres and stem cells - Building blocks associated with ageing

    Prof. Dr. Lenhard Rudolph a well-known stem cell researcher at Ulm University is investigating the relationships between telomeres stem cell ageing and diseases. In the following interview with Walter Pytlik BioRegion Ulm Rudolph gives insights into state-of-the-art ageing research and its potential applications.

    https://www.gesundheitsindustrie-bw.de/en/article/news/telomeres-and-stem-cells-building-blocks-associated-with-ageing
  • Article - 28/11/2008

    Skin might be able to close the translation gap

    Karin Scharffetter-Kochanek dermatologist and head of the Department of Dermatology and Allergology at the University Hospital of Ulm has spent a long time investigating skin ageing. Her specific focus on skin has not however restricted her understanding of ageing to barely deterministic or mechanistic details. Quite the opposite is true.

    https://www.gesundheitsindustrie-bw.de/en/article/news/skin-might-be-able-to-close-the-translation-gap
  • Article - 22/11/2008

    How is the brain capable of recognizing different odours?

    Professor Giovanni Galizia from Constance is investigating the processing of odour cues. Together with other scientists Galizia has initiated a DFG research priority on olfactory processing in humans and animals.

    https://www.gesundheitsindustrie-bw.de/en/article/news/how-is-the-brain-capable-of-recognizing-different-odours
  • Dossier - 20/11/2008 width=

    Anti-Ageing is still a far-off dream

    Is it possible to halt the ageing process? This question was first raised in the 1980s when researchers succeeded in delaying the ageing process in threadworms by modifying a specific gene. Nowadays hundreds of gene mutations are known to prolong the lifespan of yeast fruit flies and mice. Will the human dream of eternal youth eventually become reality? The truth is probably not.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/anti-ageing-is-still-a-far-off-dream
  • Article - 19/11/2008

    cr.appliance- integrated concepts in drug development

    Karen Grave-Hermann and Dr. Robert Hermann founded cr.applications in 2003. The two specialists who have wide-ranging experience in drug development talked to Michael Statnik about current trends in their field and about the development of the German biotech sector.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cr-appliance-integrated-concepts-in-drug-development
  • Article - 16/11/2008

    Looking for a formula to determine biological age

    The Europe-wide MARK-AGE project involving scientists from 14 countries commenced on the 1st April 2008. Scientists have joined forces to investigate the factors involved in ageing. They are using standardised questionnaires and analysing data acquired from physical and biochemical examinations of the blood and urine from 3700 volunteers. The team of experts includes the medical expert Professor Alexander Bürkle and the mathematician Prof.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/looking-for-a-formula-to-determine-biological-age
  • Article - 15/11/2008

    What has mathematics got to do with drugs?

    Prof. Johannes Schropp and Gilbert Koch from the University of Constance are developing mathematical models for the pharmaceutical company Nycomed. These models examine the relationship between the concentration and the effect of administered drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/news/what-has-mathematics-got-to-do-with-drugs
  • Article - 15/11/2008

    Nycomed’s Daxas® shows encouraging preliminary results

    Nycomed has announced encouraging results from a preliminary analysis of four Phase III trials of Daxas roflumilast in the treatment of symptomatic COPD. The application for marketing authorisation of the drug is expected for 2009.

    https://www.gesundheitsindustrie-bw.de/en/article/news/nycomed-s-daxas-shows-encouraging-preliminary-results
  • Article - 13/11/2008

    Ageing stem cells loose ability to adhere to stroma

    Hartmut Geiger a biochemist and stem cell researcher at Ulm University Hospital is using genetic methods to investigate the molecular basis of the physiological ageing of haematopoietic stem cells. After having spent a period in Cincinnati Geiger is currently head of the clinical research group Molecular and cellular ageing from the mechanisms of action to clinical perspectives.

    https://www.gesundheitsindustrie-bw.de/en/article/news/ageing-stem-cells-loose-ability-to-adhere-to-stroma
  • Article - 06/11/2008

    Skin models instead of rabbits

    At a meeting at the Federal Institute for Risk Assessment in Berlin an international expert committee of the Organisation for Economic Co-operation and Development agreed on a new alternative test method involving no animal experiments to determine the irritant properties of foreign substances on the skin.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/skin-models-instead-of-rabbits
  • Press release - 01/11/2008 Portrait of Dr. Christine Kranz und Prof. Dr. Boris Mizaikoff

    Boris Mizaikoff and Christine Kranz – on the way to systems analytics

    The two chemists Boris Mizaikoff and Christine Kranz have a great deal in common they are married to each other they have children together and they work at the same university on projects that combine technologies and methods to create multifunctional analytical platforms at the Department of Analytical and Bioanalytical Chemistry at Ulm University.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/boris-mizaikoff-and-christine-kranz-on-the-way-to-systems-analytics
  • Article - 25/10/2008

    Innovative anti-smoking cure programme

    The Ludwig Heilmeyer Tumour Centre Comprehensive Cancer Centre Freiburg has received a grant from the Pfizer Foundation USA for an innovative anti-smoking cure programme developed as part of the CCCFs cancer prevention strategy.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/innovative-anti-smoking-cure-programme
  • Article - 24/10/2008

    The game needs to be discovered

    Prof. Dr. Michael Reth is active in the field of immunology and signalling. He is an experienced scientist who is well aware of the difficulty and the cumbersome nature of deciphering signals and signalling pathways. The Freiburg bioss excellence cluster - the Centre of Biological Signalling Studies - is Reths brainchild. Karin Bundschuh from BioRegio Freiburg spoke with the scientist who works at the Max Planck Institute of Immunobiology and the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-game-needs-to-be-discovered
  • Press release - 21/10/2008

    Michael Boppré – chemo-ecologist driven by curiosity

    During his school days Boppr used to spend his summer holidays at the Max Planck Institute of Behavioural Physiology in Seewiesen in southern Germany. Later on as a student at the MPI he developed an interest in the love life of butterflies. Prof. Dr. Michael Boppr a chemo-ecologist at the University of Freiburg is still fascinated by organismic biology but he is convinced that this discipline is treated as very much the poor cousin to other…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/michael-boppr-chemo-ecologist-driven-by-curiosity
  • Press release - 20/10/2008

    Ultra fast magnetic resonance imaging

    The European Research Council is to fund a project at the University Hospital of Freiburg on the development of ultra fast magnetic resonance imaging for applications in the fields of neurology the neurosciences and oncology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ultra-fast-magnetic-resonance-imaging
  • Press release - 17/10/2008

    "Stem cell crazy"

    For three days from 9 to 11 October more than 300 scientists from over 20 countries met at the Haus der Wirtschaft in Stuttgart to discuss the current state of research the latest product developments and therapies in regenerative medicine and stem cell research.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/stem-cell-crazy
  • Press release - 17/10/2008

    Three anti-diabetes compounds in advanced clinical testing

    Boehringer Ingelheim has three oral compounds for the treatment of diabetes type II in phase II and III of clinical development. The most advanced compound a DPP-4 inhibitor is in the final clinical phase.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/three-anti-diabetes-compounds-in-advanced-clinical-testing
  • Press release - 15/10/2008 Portrait of Prof. Dr. Hans-Jürgen Apell

    Hans-Jürgen Apell - insights into active ion transport

    Biophysicist Prof. Hans-Jürgen Apell carries out basic research at the University of Constance in order to elucidate the molecular mechanisms involved in the transport of ions through membranes and to come up with important findings for new therapeutic concepts. His major field of research focuses on structure-function relationships of P-type ATPases enzymes which cleave ATP adenosine triphosphate and transport ions thereby resulting in muscle…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hans-juergen-apell-insights-into-active-ion-transport
  • Article - 13/10/2008 A picture of Dolly.

    Eurobarometer: animal cloning for food production

    A Flash Eurobarometer study reveals that European citizens have a generally negative perception of animal cloning for food production. 81 per cent feels that the long term effects of animal cloning are unknown.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/eurobarometer-animal-cloning-for-food-production
  • Article - 11/10/2008

    Landesstiftung foundation to fund life sciences projects

    The supervisory board of the Landesstiftung foundation has approved a total of 24.39 million euros in research funding including 5 million for strategic research and 0.5 million euros for a study on strategic research.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/landesstiftung-foundation-to-fund-life-sciences-projects
  • Press release - 07/10/2008

    GENEDATA SCREENER® – specialised data analysis for the identification of high-potential lead structures

    Genedata AG has developed a modular software system known as Genedata Screener that is tailored to screening and hit-to-lead applications. Dr. Timo Wittenberg who works at the companys site in Constance Germany told us about the advantages of the software for identifying high-potential leads.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/genedata-screener-specialised-data-analysis-for-the-identification-of-high-potential-lead-structures
  • Press release - 06/10/2008

    Harald zur Hausen wins Nobel Prize in Medicine

    Harald zur Hausen the long-time chairman and scientific director of the German Cancer Research Centre DKFZ a member of the Helmholtz Society discovered that human papillomaviruses HPV lead to cervical cancer. His discovery led to the development of a vaccine for cervical cancer which is the third most frequent type of cancer in women.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/harald-zur-hausen-wins-nobel-prize-in-medicine
  • Press release - 01/10/2008

    Karin Scharffetter-Kochanek: research that gets under the skin

    Prof. Karin Scharffetter-Kochanek has recently become a member of the renowned Leopoldina Academy of Sciences. In her research the skin has become a model system that serves as the basis for a trans-organ systemic approach looking at the underlying mechanisms and the complex interactions with other organs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/karin-scharffetter-kochanek-research-that-gets-under-the-skin

Page 37 / 42

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 42
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search